| Autor: |
D, Schonenberg, M, van Meeteren, R G, Nelissen, I E, van der Horst-Bruinsma, R G, Pöll, M T, Nurmohamed |
| Jazyk: |
Dutch; Flemish |
| Rok vydání: |
2003 |
| Předmět: |
|
| Zdroj: |
Nederlands tijdschrift voor geneeskunde. 147(38) |
| ISSN: |
0028-2162 |
| Popis: |
Establish the use of thromboprophylaxis in orthopaedic surgery both during and after the hospital admission.Cross-sectional study.In April 2002, a letter was sent to all orthopaedic surgeons in the Netherlands announcing that at every hospital with a Department of Orthopaedic Surgery, an orthopaedic surgeon would be approached for a telephone survey. They were phoned in the months April-June 2002. This study included hospitals where major orthopaedic surgery (e.g. the insertion of hip or knee prostheses and hip fracture surgery) took place (n = 124) as well as clinics that only performed day treatments (n = 5).For major orthopaedic operations, 91% of the hospitals used low molecular weight heparin (LMWH) during the admission period: 36% as monotherapy and 55% in combination with coumarin derivates. In 85% of cases the use of LMWH was started preoperatively. Coumarin derivates were used as a monotherapy in 9% of the hospitals. In 37% of the hospitals the use of NSAIDs was continued, particularly in patients with rheumatoid arthritis. In 94% of the hospitals, the use of acetylsalicylic acid was always stopped. In 97% of the hospitals prophylaxis was given after discharge in the form of LMWH (37% of the cases) or coumarin derivates (63% of the cases). The use of thromboprophylaxis with respect to arthroscopies and plaster immobilisation was variable. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
